NO20032426L - Forbindelse for chelatering av et metall, radiofarmasöytiske midler, fremstillingsprosess derfor og diagnostisk sett - Google Patents

Forbindelse for chelatering av et metall, radiofarmasöytiske midler, fremstillingsprosess derfor og diagnostisk sett

Info

Publication number
NO20032426L
NO20032426L NO20032426A NO20032426A NO20032426L NO 20032426 L NO20032426 L NO 20032426L NO 20032426 A NO20032426 A NO 20032426A NO 20032426 A NO20032426 A NO 20032426A NO 20032426 L NO20032426 L NO 20032426L
Authority
NO
Norway
Prior art keywords
chelating
present
metal
compound
diagnostic
Prior art date
Application number
NO20032426A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032426D0 (no
Inventor
Laurent Mauclaire
Eric Berthommier
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20032426D0 publication Critical patent/NO20032426D0/no
Publication of NO20032426L publication Critical patent/NO20032426L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20032426A 2000-11-29 2003-05-28 Forbindelse for chelatering av et metall, radiofarmasöytiske midler, fremstillingsprosess derfor og diagnostisk sett NO20032426L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0015416A FR2817259B1 (fr) 2000-11-29 2000-11-29 Compose de chelation d'un metal, radiopharmaceutique, procede de fabrication de ceux-ci et trousse de diagnostic
PCT/IB2001/002141 WO2002044175A2 (en) 2000-11-29 2001-11-12 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit

Publications (2)

Publication Number Publication Date
NO20032426D0 NO20032426D0 (no) 2003-05-28
NO20032426L true NO20032426L (no) 2003-05-28

Family

ID=8857008

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032426A NO20032426L (no) 2000-11-29 2003-05-28 Forbindelse for chelatering av et metall, radiofarmasöytiske midler, fremstillingsprosess derfor og diagnostisk sett

Country Status (9)

Country Link
US (1) US20040043920A1 (de)
EP (1) EP1337532B1 (de)
JP (1) JP2004514721A (de)
AT (1) ATE295364T1 (de)
AU (1) AU2002212623A1 (de)
DE (1) DE60110826D1 (de)
FR (1) FR2817259B1 (de)
NO (1) NO20032426L (de)
WO (1) WO2002044175A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1654005A4 (de) * 2003-07-24 2011-06-15 Bracco Imaging Spa Stabile radiopharmazeutische zusammensetzungen und herstellungsverfahren
MXPA06007059A (es) * 2003-12-22 2006-08-23 Astellas Pharma Inc Derivados de ornitina como agonistas o antagonistas de prostaglandina e2.
CN105949100B (zh) * 2016-05-18 2017-12-19 浙江云涛生物技术股份有限公司 新型二硫代氨基甲酸盐类重金属螯合剂的生产工艺
CN106588729B (zh) * 2016-12-06 2021-05-28 青岛柏森环保工程有限公司 一种多硫代酰肼型重金属螯合剂的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents

Also Published As

Publication number Publication date
NO20032426D0 (no) 2003-05-28
ATE295364T1 (de) 2005-05-15
WO2002044175A2 (en) 2002-06-06
EP1337532B1 (de) 2005-05-11
DE60110826D1 (de) 2005-06-16
WO2002044175A3 (en) 2002-08-15
AU2002212623A1 (en) 2002-06-11
FR2817259B1 (fr) 2003-02-21
US20040043920A1 (en) 2004-03-04
EP1337532A2 (de) 2003-08-27
FR2817259A1 (fr) 2002-05-31
JP2004514721A (ja) 2004-05-20

Similar Documents

Publication Publication Date Title
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
IL172403A (en) D-amino acid peptides
ATE423130T1 (de) Deuterierte cyclosporin-analoga und ihre verwendung als immunmodulierende agenzien
TNSN04017A1 (en) N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
MY110526A (en) Thioether conjugates
PL369119A1 (en) Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
HUP0401738A2 (hu) Prolin után hasító proteázok inhibitorai és ezeket tartalmazó gyógyszerkészítmények
MXPA04002785A (es) Aminas sustituidas para tratamiento de enfermedad de alzheimer.
EP0635001A1 (de) Substituierte thioharnstoffe als bifunktionelle chelatoren.
DE69527975D1 (de) Humanisierte antikörper gegen cd38
ATE237365T1 (de) Technetium-99-markierte peptide zur visualisierung vom entzuendungen
TW200512195A (en) Benzamide 2-hydroxy-3-diaminoalkanes
MX338829B (es) Metodo para preparar 3-halo-4,5-dihidro-1h-pirazoles.
MXPA04000210A (es) Conjugados quelantes mejorados.
MXPA03011466A (es) Macrociclos utiles en tratamiento de enfermedades de alzheimer.
MXPA03011521A (es) Aminadioles para tratamiento de enfermedad de alzheimer.
NO20032426L (no) Forbindelse for chelatering av et metall, radiofarmasöytiske midler, fremstillingsprosess derfor og diagnostisk sett
FR2818906B1 (fr) Association medicamenteuse d&#39;une biguanine et d&#39;un transporteur, par exemple de metformine et d&#39;arginine
AU2002356991A1 (en) Amino acid derivatives useful for the treatment of alzheimer&#39;s disease
BG103751A (bg) Метод за получаване на междинни съединения за синтез на пестициди
MXPA03011502A (es) Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer.
MXPA04000337A (es) Amindioles para tratamiento de enfermedad de alzheimer.
SG43028A1 (en) Process for the preparation of an alpha-amino acid amide which may be used in peptide synthesis
JP2019533664A (ja) スズ(iv)からスズ(ii)を生成させ、分離する方法